Costs and disease activity in early rheumatoid arthritis in 1996-2000 and 2006-2011, improved outcome and shift in distribution of costs: a two-year follow-up
Authors:
- 1 January 2018
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 47 (5) , 378-383
Abstract
Objective: To evaluate changes in healthcare utilization, costs, and disease activity from 1996 to 2011 for patients with early rheumatoid arthritis (RA).Method: Two cohorts of patients with early RA, included in 1996-1998 (T1) and 2006-2009 (T2), were followed regularly. Healthcare utilization, costs, and disease activity were compared between cohorts during 2years after diagnosis.Results: Disease activity was significantly improved in T2 vs T1. Drug costs increased in T2 vs T1 (EUR 911 vs EUR 535, respectively; p=0.017), and costs for RA-related hospitalization decreased. More than 90% in T2 were prescribed disease-modifying anti-rheumatic drugs (DMARDs) at inclusion compared to 50% in T1. At 2year follow-up, levels were still >90% in T2, while corresponding values in T1 were just above 70%. Comparing T2 to T1, total direct costs were slightly higher in T2 (EUR 3941 vs EUR 3364, respectively; ns), sick leave decreased (EUR 3511 vs EUR 5672; p=0.025), while disability pension increased slightly (EUR 4889 vs EUR 4244; ns), but total indirect costs remained unchanged (EUR 8400 vs EUR 9916; ns). Total direct and indirect costs did not differ between the cohorts (EUR 12342 in T2 vs EUR 13280 in T1; ns), and loss of productivity still represented the largest component of total costs.Conclusion: T2 patients were prescribed DMARDs earlier and more aggressively than T1 patients. Stable and better improvements in disease activity, function, and quality of life were achieved in T2 compared to T1. There was a shift within the components in direct costs and indirect costs, but total costs remained essentially unchanged.Keywords
Funding Information
- Medical Research County Council of South-East Sweden
- County Council in Östergötland
This publication has 14 references indexed in Scilit:
- Evaluating relationships between symptom duration and persistence of rheumatoid arthritis: does a window of opportunity exist? Results on the Leiden Early Arthritis Clinic and ESPOIR cohortsAnnals of the Rheumatic Diseases, 2015
- The Burden of Disease in Rheumatoid ArthritisPharmacoEconomics, 2014
- Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA projectScandinavian Journal of Rheumatology, 2013
- Costs of rheumatoid arthritis during the period 1990-2010: a register-based cost-of-illness study in SwedenRheumatology, 2013
- Changes in Utilization and Costs for Patients with Rheumatoid Arthritis, 1997 to 2006PharmacoEconomics, 2012
- The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agentsRheumatology, 2011
- Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savingsRheumatology, 2010
- Changes in the rates of joint surgery among patients with rheumatoid arthritis in California, 1983–2007Annals of the Rheumatic Diseases, 2010
- The economics of treatment in early rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2009
- How should cost data in pragmatic randomised trials be analysed?BMJ, 2000